Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, and adoptive cell therapies announced the election of Dr. Allison Jeynes-Ellis to Agenus’ Board of Directors.
You can find the full press release here.